About Blue Horizon International
Blue Horizon International (BHI) is a healthcare consulting company founded in 2009 by orthopedic surgeon Brian Mehling, MD. BHI combines scientific research, education, and philanthropy.
Through BHI Therapeutic Sciences, BHI supports investigational research in stem cell science and regenerative medicine, conducted under Institutional Review Board oversight and in collaboration with academic and clinical partners. Through the Blue Horizon Charitable Foundation, BHI supports access to medical care for underserved children and adults.
Blue Horizon International does not provide medical treatment or patient care in the United States. Its cellular products are investigational, have not been shown to be safe or effective for any disease or condition, and are not approved by the U.S. Food and Drug Administration.